Clinical Trials Study
Copyright ©The Author(s) 2021.
World J Gastroenterol. Aug 7, 2021; 27(29): 4900-4912
Published online Aug 7, 2021. doi: 10.3748/wjg.v27.i29.4900
Table 1 Demographic data and clinical parameters on admission
Variable
Value
Age (yr)67.0 (63.0-72.3)
Sex (Male:female)29:25
BMI (kg/m2)24.3 (21.5-27.0)
Etiology of sepsis, n (%)
Abdominal infection27 (50.0)
Thoracic/pulmonary infection10 (18.5)
Blood stream infection6 (11.1)
Urinary infection6 (11.1)
Mucocutaneous infection3 (5.6)
Other2 (3.7)
Initial AGI grade, n (%)
I13 (31.5)
II24 (55.6)
III5 (13.0)
APACHEII score22.0 (19.5-27.8)
SOFA score9.5 (8.0-11.8)
Feeding intolerance, n (%)16 (29.6)
Need for MV, n (%)49 (90.7)
Need for CRRT, n (%)20 (37.0)
MV-free days19.5 (1.8-22.8)
CRRT-free days23.0 (13.3-27.0)
ICU-free days17.0 (0.0-22.8)
MODS, n (%)20 (37.0)
Death, n (%)14 (25.9)
Table 2 Number of patients with feeding intolerance and clinical severity and outcome variables

Group A (n = 17)
Group B (n = 18)
Group C (n = 19)
P value
Feeding intolerance, n (%)2 (11.8)4 (22.2)10 (52.6)0.019
MV-free days19.0 (0.0-21.0)22.0 (1.0-25.0)18.0 (4.0-22.5)0.347
CRRT-free days20.0 (12.0-28.0)26.0 (7.8-28.0)22.0 (14.5-28.0)0.778
ICU-free days19.0 (0.0-23.0)19.0 (0.0-21.8)16.0 (0.0-21.0)0.572
MODS, n (%)6 (35.3)8 (44.4)6 (31.6)0.709
Death, n (%)4 (23.5)5 (27.8)5 (26.3)0.856
Table 3 Incidence of feeding intolerance symptoms, n (%)
Group A (n = 17 × 7)Group B (n = 18 × 7)Group C (n = 19 × 7)P value
Feeding intolerance6 (5.0)11 (8.7)22 (16.5)0.009
Nausea or vomiting2 (1.7)3 (2.4)3 (2.3)0.758
Diarrhea2 (1.7)2 (1.6)8 (6.0)0.046
Abdominal pain0 (0.0)0 (0.0)1 (0.8)0.238
Abdominal distention1 (0.8)2 (1.6)6 (4.5)0.054
High gastric residuals1 (0.8)2 (1.6)2 (1.5)0.653
IAH0 (0.0)1 (0.8)1 (0.8)0.422
Paralytic ileus0 (0.0)1 (0.8)1 (0.8)0.444